广发纳斯达克生物科技美元(001093)
动态评分： 2.54分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2021-12-31 | ALVR | AlloVir Inc | 10.23 | 0.07% |
| 2021-12-31 | ARCT | Arcturus Therapeutics Holdings Inc | 9.41 | 0.07% |
| 2021-12-31 | CCCC | C4 Therapeutics Inc | 10.39 | 0.07% |
| 2021-12-31 | ENDP | 远藤制药 | 9.83 | 0.07% |
| 2021-12-31 | GOSS | Gossamer Bio Inc | 9.4 | 0.07% |
| 2021-12-31 | IDYA | IDEAYA生物科学 | 9.53 | 0.07% |
| 2021-12-31 | IMVT | Immunovant Inc | 10.46 | 0.07% |
| 2021-12-31 | INO | Inovio制药 | 10.39 | 0.07% |
| 2021-12-31 | MGNX | MacroGenics Inc | 10.49 | 0.07% |
| 2021-12-31 | MGTX | MeiraGTx Holdings plc | 10.22 | 0.07% |
| 2021-12-31 | QURE | uniQure NV | 10.39 | 0.07% |
| 2021-12-31 | RPTX | Repare Therapeutics Inc | 9.8 | 0.07% |
| 2021-12-31 | RUBY | Rubius Therapeutics Inc | 9.89 | 0.07% |
| 2021-12-31 | RXDX | Prometheus Biosciences Inc | 10.21 | 0.07% |
| 2021-12-31 | STOK | Stoke Therapeutics Inc | 9.9 | 0.07% |
| 2021-12-31 | AKRO | Akero Therapeutics Inc | 8.7 | 0.06% |
| 2021-12-31 | ANAB | AnaptysBio Inc | 9.33 | 0.06% |
| 2021-12-31 | ATAI | ATAI Life Sciences NV | 8.12 | 0.06% |
| 2021-12-31 | AVXL | Anavex Life Sciences Corp | 8.74 | 0.06% |
| 2021-12-31 | BCYC | Bicycle Therapeutics Ltd ADR | 8.03 | 0.06% |
公告&资料
